☆ 4.6 Article

Revisiting asthma pharmacotherapy: where do we stand and where do we want to go?

EUROPEAN RESPIRATORY JOURNAL (2023)

Related references

Note: Only part of the references are listed.

Article Allergy

Comparative effectiveness of omalizumab, mepolizumab, and dupilumab in asthma: A target trial emulation

Ayobami T. Akenroye et al.

Summary: This study compared the effectiveness of omalizumab, mepolizumab, and dupilumab in patients with asthma. The results showed that among patients with asthma and peripheral eosinophil counts of at least 150 cells/μL and IgE levels of 30 to 700 kU/L, dupilumab was associated with greater improvements in asthma exacerbations and FEV1 value compared to omalizumab and mepolizumab.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)

Add to Collection

Article Multidisciplinary Sciences

Efficacy and safety of GSK3772847 in participants with moderate-to-severe asthma with allergic fungal airway disease: A phase IIa randomized, multicenter, double-blind, sponsor-open, comparative trial

Chika Akinseye et al.

Summary: This randomized, double-blind trial assessed the efficacy and safety of GSK3772847 in moderate-to-severe asthma patients with allergic fungal airway disease. The study was terminated early due to small sample size and lack of clinical benefits. Larger prospective studies are needed.

PLOS ONE (2023)

Add to Collection

Article Pharmacology & Pharmacy

Development of an inhaled anti-TSLP therapy for asthma

Paul M. O'Byrne et al.

Summary: In this paragraph, the role of thymic stromal lymphopoietin (TSLP) in asthma pathogenesis and the potential of TSLP blockade as a therapeutic option are discussed. Currently approved biologic treatments for asthma target specific phenotypes, and there is a need for a therapy that can address both Type 2- high and Type 2-low inflammation. Ecleralimab, an inhaled anti-TSLP antibody fragment, is being developed as a potential treatment for severe uncontrolled asthma.

PULMONARY PHARMACOLOGY & THERAPEUTICS (2023)

Add to Collection

Article Allergy

Super-Responders to Biologic Treatment in Type 2–High Severe Asthma: Passing Fad or a Meaningful Phenotype?

Andrea Portacci et al.

Journal of Allergy and Clinical Immunology-In Practice (2023)

Add to Collection

Review Allergy

Treatable Traits in Airway Disease: From Theory to Practice

Alvar Agusti et al.

Summary: Chronic airway diseases, such as asthma and chronic obstructive pulmonary disease, often coexist in the same patient. The treatable traits (TT) strategy, based on identifying and treating recognizable characteristics, aims to improve clinical outcomes. TTs can coexist and are not limited to specific diagnostic labels like asthma or COPD. There is solid evidence supporting the adequacy and validity of the TT strategy, and this review discusses the theoretical background and implementation in clinical practice.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2023)

Add to Collection

Article Allergy

Toward a Predict and Prevent Approach in Obstructive Airway Diseases

Simon Couillard et al.

Summary: Asthma and chronic obstructive pulmonary disease are currently diagnosed and treated after the demonstration of variable airflow limitation and symptoms. However, undiagnosed and unchecked airway inflammation can lead to various complications. Therefore, a paradigm shift towards a predict and prevent model is proposed, where inflammation is measured early and anti-inflammatory therapy is provided to prevent further deterioration.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2023)

Add to Collection

Article Critical Care Medicine

Questions in Mild Asthma An Official American Thoracic Society Research Statement

Arjun Mohan et al.

Summary: This study aims to explore disease-associated risks and research needs in mild asthma. The team of international experts identified knowledge gaps in various aspects and emphasized the importance of patient engagement and research support in this field.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Add to Collection

Article Respiratory System

Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma

Gail M. Gauvreau et al.

Summary: The study evaluated the efficacy and safety of ecleralimab, an inhaled neutralizing antibody fragment against TSLP, in subjects with mild atopic asthma. The results showed that ecleralimab significantly reduced allergen-induced bronchoconstriction and airway inflammation, and it was safe in subjects with mild atopic asthma.

EUROPEAN RESPIRATORY JOURNAL (2023)

Add to Collection

Review Pharmacology & Pharmacy

Investigational anti IL-13 asthma treatments: a 2023 update

Maria Gabriella Matera et al.

Summary: IL-13 is an important cytokine in the development of asthma and other eosinophilic disorders. Current attempts to directly neutralize IL-13 or block its receptors have not shown significant efficacy in treating severe asthma. We suggest considering the use of anti-IL-13 drugs before GINA step 5.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2023)

Add to Collection

Review Allergy

Severe Asthma and Biologics: Managing Complex Patients

A. Matucci et al.

Summary: Bronchial asthma is a chronic respiratory disease with various clinical presentations and underlying mechanisms. Defining the phenotype/endotype is important for targeted biologic treatments. Comorbidities such as chronic rhinosinusitis, obesity, bronchiectasis, and immune deficiency can worsen asthma symptoms. Differentiating between severe eosinophilic asthma and asthma in eosinophilic granulomatosis is crucial. Managing the complex disease features of severe asthma is challenging.

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2023)

Add to Collection

Review Cardiac & Cardiovascular Systems

Cardiovascular disease in asthma patients: From mechanisms to therapeutic implications

Mario Cazzola et al.

Summary: Cardiovascular disease and asthma are strongly linked, with asthma patients having an increased risk of death from cardiovascular disease. The presence of airway and systemic inflammation in both asthma and cardiovascular disease is believed to contribute to these cardiovascular complications. Understanding the underlying mechanisms is crucial for selecting appropriate pharmacological interventions.

KARDIOLOGIA POLSKA (2023)

Add to Collection

Review Primary Health Care

Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update

Mark L. Levy et al.

Summary: The Global Initiative for Asthma (GINA) was established in 1993 to improve asthma awareness, prevention and management worldwide. GINA develops evidence-based resources for clinicians and its guidance is adopted by national asthma guidelines in many countries. GINA is funded independently and supports individualized assessment and treatment for asthma.

NPJ PRIMARY CARE RESPIRATORY MEDICINE (2023)

Add to Collection

Article Pharmacology & Pharmacy

Anti-IL-33 monoclonal antibody Treatment of COPD and asthma Treatment of atopic dermatitis Treatment of diabetic kidney disease

Mario Cazzola et al.

Summary: IL-33 is a cytokine that may play a role in the pathogenesis of asthma, atopic dermatitis, and COPD through its interaction with ST2 and IL-1RAP receptors. Tozorakimab, a human IgG1 monoclonal antibody, shows promise in inhibiting IL-33 signaling without safety concerns. Further investigation of the efficacy and safety of tozorakimab in COPD, asthma, and other inflammatory diseases is ongoing.

DRUGS OF THE FUTURE (2023)

Add to Collection

Editorial Material Critical Care Medicine

Endotyping Asthma: Profiling the Metabolic Dimension?

Michael J. Wilde et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Add to Collection

Article Immunology

Should we apply a treatable traits approach to asthma care?

Dr James Melhorn et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2022)

Add to Collection

Article Respiratory System

Global initiative for Asthma Strategy 2021: executive summary and rationale for key changes

Helen K. Reddel et al.

Summary: The GINA Strategy Report provides clinicians with an evidence-based strategy for asthma management and prevention, with specific recommendations and treatment options for different age groups and severity levels. Regular personalized assessment, treatment of modifiable risk factors, and appropriate medication adjustment and review remain essential for optimizing asthma outcomes.

EUROPEAN RESPIRATORY JOURNAL (2022)

Add to Collection

Editorial Material Allergy

Tezepelumab administration in moderate-to-severe uncontrolled asthma: Is it all about eosinophils?

Pier Giorgio Puzzovio et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Add to Collection

Review Allergy

Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma

Celeste M. Porsbjerg et al.

Summary: The study identified significant differences in prescription criteria for biologics among 28 countries, posing a challenge to the implementation of personalized medicine for severe asthma treatment globally.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)

Add to Collection

Article Health Care Sciences & Services

Which Therapy for Non-Type(T)2/T2-Low Asthma

Fabio L. M. Ricciardolo et al.

Summary: Currently, asthma is divided into T2-high and non-T2/T2-low types, with T2-low asthma lacking a clear definition. T2-low patients have minimal or no expression of T2-high biomarkers. The molecular mechanisms and biological processes underlying T2-low asthma are not well-studied, but type 1 and type 3 immune responses have been recognized, as well as remodeling events without inflammation. The lack of agreed-upon biomarkers poses a challenge for finding effective therapies.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Add to Collection

Review Allergy

Single inhaler triple therapy (SITT) in asthma: Systematic review and practice implications

Alvar Agusti et al.

Summary: Research has shown that adding LAMA can improve outcomes in patients with uncontrolled asthma despite ICS/LABA treatment. SITT has been proven to be a safe and effective alternative treatment option.

ALLERGY (2022)

Add to Collection

Review Allergy

T2-low: what do we know? Past, present, and future of biologic therapies in noneosinophilic asthma

Natalie M. Niessen et al.

Summary: Several monoclonal antibodies targeting non-T2 cytokines were previously reported to be ineffective in asthma, but more tailored approaches in selecting participants based on specific biomarkers have shown promising results. Subgroup analyses in T2-low asthma populations have revealed positive outcomes and a stronger treatment response. Understanding specific biomarkers and T2-low subgroups is essential in identifying the most responsive target population for a given monoclonal antibody.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2022)

Add to Collection

Article Respiratory System

Asthma remission: what is it and how can it be achieved?

Dennis Thomas et al.

Summary: This review discusses the definitions, prevalence, predictors, pathophysiology, treatment possibilities, and research directions of asthma remission. Remission is characterized by high level of disease control and normalized or optimized lung function. Even in symptomatic remission, persistent pathological abnormalities and risk of relapse exist. The prevalence of remission varies between 2% and 52% in adult asthma population. Factors associated with remission include mild asthma, better lung function, better asthma control, younger age, early-onset asthma, shorter duration of asthma, milder bronchial hyperresponsiveness, fewer comorbidities, and smoking cessation or never smoking. Current long-term add-on therapies can achieve some criteria for remission in a subgroup of patients. Further research is required to evaluate remission as a treatment goal.

EUROPEAN RESPIRATORY JOURNAL (2022)

Add to Collection

Review Pharmacology & Pharmacy

An update on the currently available and emerging synthetic pharmacotherapy for uncontrolled asthma

Mario Cazzola et al.

Summary: The use of synthetic pharmacotherapy is a potential alternative to overcome resistance to corticosteroids and limitations of biological therapies for uncontrolled asthma. Certain pathways have been identified as potential targets for the development of new drugs against asthma.

EXPERT OPINION ON PHARMACOTHERAPY (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Corticosteroid resistance in asthma: Cellular and molecular mechanisms

Gaetano Caramori et al.

Summary: Inhaled glucocorticoids (GCs) are widely used to treat asthma patients. They prevent the activation of immune and inflammatory cells in the lungs and have significant effects on airway structure. However, some patients show poor asthma control even with high doses of GCs, which may be due to GC resistance.

MOLECULAR ASPECTS OF MEDICINE (2022)

Add to Collection

Article Medicine, General & Internal

Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma

Alberto Papi et al.

Summary: The fixed-dose combination of albuterol and budesonide as rescue medication reduces the risk of severe asthma exacerbation and shows similar safety compared to albuterol alone for patients with uncontrolled moderate-to-severe asthma.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Critical Care Medicine

Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study

Michael E. Wechsler et al.

Summary: This study evaluated the efficacy of tezepelumab in reducing oral corticosteroid dose in patients with oral corticosteroid-dependent asthma. The results showed no significant improvement in the overall population, but improvement was observed in patients with higher baseline blood eosinophil counts.

LANCET RESPIRATORY MEDICINE (2022)

Add to Collection

Review Allergy

Effectiveness of Interventions Targeting Treatable Traits for the Management of Obstructive Airway Diseases: A Systematic Review and Meta-Analysis

Muhammad Rehan Sarwar et al.

Summary: This study investigated the effectiveness of interventions targeting treatable traits (TTs) for managing obstructive airway diseases (OADs). The meta-analyses showed that TT interventions were effective in improving health-related quality of life, reducing hospitalizations, decreasing all-cause-1-year mortality, alleviating dyspnea, anxiety, and depression in OADs.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)

Add to Collection

Review Allergy

Potential Drawbacks of ICS/LABA/LAMA Triple Fixed-Dose Combination Therapy in the Treatment of Asthma: A Quantitative Synthesis of Safety Profile

Paola Rogliani et al.

Summary: Triple FDC is a safe pharmacological therapy in severe asthmatic patients, characterized by a favorable safety profile and few potential drawbacks, although it may increase the risk of vascular serious adverse events.

JOURNAL OF ASTHMA AND ALLERGY (2022)

Add to Collection

Article Allergy

Phenotypes of Asthma-Chronic Obstructive Pulmonary Disease Overlap

Muhammad Adrish et al.

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2022)

Add to Collection

Article Allergy

Unmet Needs and the Future of Asthma-Chronic Pulmonary Obstructive Disease Overlap

Mario Cazzola et al.

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2022)

Add to Collection

Article Allergy

Pharmacologic Management Strategies of Asthma-Chronic Obstructive Pulmonary Disease Overlap

Nicola A. Hanania et al.

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2022)

Add to Collection

Review Respiratory System

Clinical characteristics, treatment patterns and adherence in patients with asthma on multiple inhaler triple therapy: a review of findings

Mario Cazzola et al.

Summary: The use of MITT in asthma patients is not very common, but it has been shown to improve lung function and reduce severe exacerbations. However, concerns about device adherence and persistence, as well as the fear of discontinuing ICS/LABA but not LAMA, may contribute to the limited use of MITT. While the current trend favors the SITT approach, some physicians may choose to prescribe MITT in order to titrate the individual components of triple therapy. Further real-life studies are needed to determine when SITT should be preferred over MITT.

EXPERT REVIEW OF RESPIRATORY MEDICINE (2022)

Add to Collection

Review Immunology

Monoclonal antibodies in the management of asthma: Dead ends, current status and future perspectives

Grzegorz Kardas et al.

Summary: Clinical data suggest that monoclonal antibody treatments targeting key inflammatory cytokines in asthma can reduce exacerbation rates, improve lung function, increase asthma control, and enhance quality of life. However, there is still a need for additional therapies as some patients do not respond well to existing antibodies. Research is ongoing to develop biologics targeting different immunological pathways.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

The 5T approach in asthma: Triple Therapy Targeting Treatable Traits

Mario Cazzola et al.

Summary: Using a therapeutic strategy based on treatable traits may help overcome challenges in identifying and validating asthma phenotypes and endotypes. Triple therapy using a single inhaler has been shown to be effective in managing uncontrolled asthma and preventing exacerbations. Identifying treatable traits allows for a treatment strategy that is closer to precision medicine.

RESPIRATORY MEDICINE (2022)

Add to Collection

Article Respiratory System

Treatable traits in the NOVELTY study

Alvar Agusti et al.

Summary: This study assessed the prevalence and relationship of treatable traits (TTs) to the diagnostic label and disease severity in real-world setting for patients with asthma, COPD, or both. The results provide the largest and most granular characterization of TTs in patients with airway diseases to date.

RESPIROLOGY (2022)

Add to Collection

Article Allergy

Adherence and Persistence to Single-Inhaler Versus Multiple-Inhaler Triple Therapy for Asthma Management

Carlyne M. Averell et al.

Summary: This study compared adherence and persistence among adult asthma patients receiving single-inhaler FF/UMEC/VI versus multiple-inhaler triple therapy (MITT) in the United States, and found that patients initiating triple therapy with FF/UMEC/VI had significantly better adherence and persistence compared with MITT initiators.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)

Add to Collection

Article Allergy

Efficacy and Safety of Masitinib in Corticosteroid-Dependent Severe Asthma: A Randomized Placebo-Controlled Trial

Lavinia Davidescu et al.

Summary: Orally administered masitinib reduces the risk of asthma exacerbations in severe asthma patients and has an acceptable safety profile. It may potentially provide a new treatment option for oral corticosteroid-dependent severe asthma.

JOURNAL OF ASTHMA AND ALLERGY (2022)

Add to Collection

Review Pharmacology & Pharmacy

Pharmacological approaches to target type 2 cytokines in asthma

Laurent Guilleminault et al.

Summary: Asthma, affecting over 250 million people worldwide, is the most common chronic lung disease. The heterogeneity of asthma phenotypes poses challenges in assessing and treating the disease. However, approximately 50% of asthma patients exhibit chronic type 2 inflammation triggered by certain cytokines, making these cytokines important therapeutic targets in asthma treatment. This article discusses the structure and functions of these cytokines in asthma and reviews the current therapies and novel strategies targeting these cytokines or their receptors.

PHARMACOLOGY & THERAPEUTICS (2022)

Add to Collection

Review Allergy

Evolving Concept of Severe Asthma: Transition From Diagnosis to Treatable Traits

So -Young Park et al.

Summary: The concept of severe asthma has evolved into a clinical syndrome with distinct pathophysiological processes. Various clinical phenotypes have been identified using cluster approaches, while cellular and molecular approaches have been used to develop biological therapies. Although these therapies have significantly improved clinical outcomes, questions on their proper use and uncontrolled asthma in some patients remain. The concept of treatable traits addresses these unmet needs and aims to achieve better personalized medical care and outcomes.

ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2022)

Add to Collection

Article Allergy

EAACI Biologicals Guidelines-Recommendations for severe asthma

Ioana Agache et al.

Summary: Severe asthma poses significant challenges in management, but targeted treatments with biologicals offer new hope for patients. However, further research is needed on issues such as selection of biologicals, response definition, treatment duration, and cost-effectiveness.

ALLERGY (2021)

Add to Collection

Review Critical Care Medicine

Severe Adult Asthmas: Integrating Clinical Features, Biology, and Therapeutics to Improve Outcomes

Sally E. Wenzel

Summary: Evaluation and management of severe asthma remains a core focus in pulmonary practice. Advances in clinical phenotyping and molecular tools have greatly enhanced our understanding and treatment of severe asthma. Challenges still exist, but conceptual understanding of the disease has evolved significantly in a relatively short period of time.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

Add to Collection

Editorial Material Critical Care Medicine

National Asthma Education and Prevention Program 2020 Guideline Update: Where Do We Go from Here?

Jerry A. Krishnan et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

Add to Collection

Article Pharmacology & Pharmacy

Prospects for severe asthma treatment

Luigino Calzetta et al.

Summary: Biological drugs have shown effectiveness in treating severe uncontrolled asthma, but there is a lack of head-to-head studies comparing the available molecules. Further molecular targets need to be identified to offer effective treatments for patients who do not respond to current biological drugs.

CURRENT OPINION IN PHARMACOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma

Michael E. Wechsler et al.

Summary: The study found that the monoclonal antibody itepekimab targeting interleukin-33 was more effective than placebo in improving lung function and reducing the incidence of loss of asthma control events in patients with moderate-to-severe asthma.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Pharmacology & Pharmacy

Indacaterol, glycopyrronium, and mometasone: Pharmacological interaction and anti-inflammatory profile in hyperresponsive airways

Paola Rogliani et al.

Summary: The study found that the combinations of IND/MF and IND/GLY/MF have synergistic effects in treating asthma, reducing airway hyperresponsiveness and modulating levels of cytokines, neurokinins, ACh, and intracellular cAMP.

PHARMACOLOGICAL RESEARCH (2021)

Add to Collection

Article Genetics & Heredity

Treatable Mechanisms in Asthma

Mario Cazzola et al.

Summary: Asthma is a heterogeneous condition, and personalized treatment could involve dividing patients into subgroups and targeting them accordingly; alternatively, managing airways disease based on treatable traits is another strategy, but challenges lie in defining these traits and understanding their mechanisms.

MOLECULAR DIAGNOSIS & THERAPY (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

SMART for the treatment of asthma: A network meta-analysis of real-world evidence

Paola Rogliani et al.

Summary: This study conducted a quantitative synthesis comparing real-world evidence of single inhaled corticosteroid/formoterol maintenance and reliever therapy (SMART) with maintenance ICS/long-acting beta 2-adrenoceptor agonist + as-needed short-acting beta 2-adrenoceptor agonist in asthmatic patients. The findings suggest that SMART may be the preferred therapeutic option to reduce the risk of severe exacerbation in adults with moderate to severe asthma.

RESPIRATORY MEDICINE (2021)

Add to Collection

Article Critical Care Medicine

Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma A Delphi Study

Carey M. Suehs et al.

Summary: In this study, expert consensus statements were developed on tapering oral corticosteroid (OCS) use in asthma patients through a modified Delphi method. Experts agreed on attempting OCS tapering in patients receiving maintenance therapy, personalizing the tapering rhythm and speed. Areas of nonconsensus were identified, emphasizing the need for further research in certain aspects of OCS use in asthma.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

Add to Collection

Editorial Material Allergy

Super-Responders to Severe Asthma Treatments: Defining a New Paradigm

Hitasha Rupani et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

Add to Collection

Review Medicine, General & Internal

Triple vs Dual Inhaler Therapy and Asthma Outcomes in Moderate to Severe Asthma A Systematic Review and Meta-analysis

Lisa H. Y. Kim et al.

Summary: The systematic synthesis of outcomes from 20 randomized clinical trials revealed that triple therapy (ICS, LABA, and LAMA) was significantly associated with reduced risk of severe asthma exacerbations and modest improvements in asthma control compared to dual therapy (ICS plus LABA), with no significant differences in quality of life or mortality.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Allergy

Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial

Steven G. Kelsen et al.

Summary: The study evaluated the efficacy and safety of Astegolimab in patients with severe asthma, showing that the drug reduced asthma exacerbation rate and had a good effect on patients with low blood eosinophils, while maintaining safety and tolerability.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma

Andrew Menzies-Gow et al.

Summary: Tezepelumab, a monoclonal antibody targeting thymic stromal lymphopoietin, effectively reduces asthma exacerbations in patients with severe, uncontrolled asthma, leading to improved lung function, asthma control, and quality of life.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

Pulmonary Functional Imaging: Part 2-State-of-the-Art Clinical Applications and Opportunities for Improved Patient Care

Warren B. Gefter et al.

Summary: Pulmonary functional imaging involves quantifying lung function regionally using CT, MRI, and nuclear medicine techniques. This method provides valuable information on ventilation, perfusion, gas exchange, and biomechanics, which is not available through conventional pulmonary function tests. Addressing challenges such as validation, establishment of normal values, and standardization of imaging acquisition and analysis is crucial for the widespread implementation of pulmonary functional imaging in routine clinical practice.

RADIOLOGY (2021)

Add to Collection

Review Chemistry, Medicinal

Role of p38 Mitogen-Activated Protein Kinase in Asthma and COPD: Pathogenic Aspects and Potential Targeted Therapies

Corrado Pelaia et al.

Summary: The p38 MAPK subgroup plays a crucial role in the pathogenesis of asthma and COPD by regulating the expression of various inflammatory mediators and fibrogenic factors. Studies suggest that p38 MAPK may be a potential therapeutic target, with research evaluating its effects in both asthma and COPD treatment.

DRUG DESIGN DEVELOPMENT AND THERAPY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Oral Corticosteroids Dependence and Biologic Drugs in Severe Asthma: Myths or Facts? A Systematic Review of Real-World Evidence

Luigino Calzetta et al.

Summary: Studies have shown that while corticosteroids are the cornerstone of asthma treatment, some severe patients may depend on oral corticosteroids. However, humanised monoclonal antibodies have been proven to have an effect in reducing dependence on oral corticosteroids.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Review Respiratory System

Step-up and step-down approaches in the treatment of asthma

Mario Cazzola et al.

Summary: The current stepping approach to asthma treatment needs to be reassessed and modified. There are significant differences in opinions on the level of asthma control between patients and physicians. A more reasonable approach that sets individualized treatment goals and associates them with treatable traits of asthma is needed.

EXPERT REVIEW OF RESPIRATORY MEDICINE (2021)

Add to Collection

Article Allergy

Defining a Severe Asthma Super-Responder: Findings from a Delphi Process

John W. Upham et al.

Summary: Using a modified Delphi process, severe asthma experts developed an international consensus-based definition of a severe asthma super-responder, with major and minor criteria established. This definition is crucial for better understanding the prevalence, predictive factors, and mechanisms involved in super-responders, emphasizing the need for further research in these areas.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

Add to Collection

Review Respiratory System

Identification and treatment of T2-low asthma in the era of biologics

Chris Kyriakopoulos et al.

Summary: The management of T2-low asthma remains a challenge due to poor response to steroids and limited candidates for targeted biologic agents. Current research is focused on identifying biomarkers for T2-low asthma and targeting neutrophilic airway inflammation as a therapeutic approach. Therapeutic targets include molecules that restore corticosteroid sensitivity, bronchodilators, anti-inflammatory agents, and airway smooth muscle mass attenuation therapies.

ERJ OPEN RESEARCH (2021)

Add to Collection

Review Allergy

The impact of the prostaglandin D2 receptor 2 and its downstream effects on the pathophysiology of asthma

Christopher E. Brightling et al.

ALLERGY (2020)

Add to Collection

Article Medicine, General & Internal

Factors that determine the loss of control when reducing therapy by steps in the treatment of moderate-severe asthma in standard clinical practice: A multicentre Spanish study

E. Martinez-Moragon et al.

REVISTA CLINICA ESPANOLA (2020)

Add to Collection

Article Allergy

The moderating role of allergy immunotherapy in asthma progression: Results of a population-based cohort study

Jochen Schmitt et al.

ALLERGY (2020)

Add to Collection

Article Respiratory System

Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline

Fernando Holguin et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

Add to Collection

Article Pharmacology & Pharmacy

Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide: Synergy of triple combination therapy on human airway smooth muscle ex vivo

Paola Rogliani et al.

BRITISH JOURNAL OF PHARMACOLOGY (2020)

Add to Collection

Review Respiratory System

Rational oral corticosteroid use in adult severe asthma: A narrative review

Li Ping Chung et al.

RESPIROLOGY (2020)

Add to Collection

Review Respiratory System

Precision medicine and treatable traits in chronic airway diseases-where do we stand?

Charlotte Suppli Ulrik et al.

CURRENT OPINION IN PULMONARY MEDICINE (2020)

Add to Collection

Article Pharmacology & Pharmacy

TSLP Inhibitors for Asthma: Current Status and Future Prospects

Maria Gabriella Matera et al.

DRUGS (2020)

Add to Collection

Article Respiratory System

Targeting treatable traits in severe asthma: a randomised controlled trial

Vanessa M. McDonald et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

Add to Collection

Review Allergy

An expert consensus framework for asthma remission as a treatment goal

Andrew Menzies-Gow et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Add to Collection

Review Pharmacology & Pharmacy

Pharmacology and Therapeutics of Bronchodilators Revisited

M. G. Matera et al.

PHARMACOLOGICAL REVIEWS (2020)

Add to Collection

Article Respiratory System

SMART and as-needed therapies in mild-to-severe asthma: a network meta-analysis

Paola Rogliani et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

Add to Collection

Review Allergy

T2-Low Asthma: Overview and Management Strategies

Anne M. Fitzpatrick et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)

Add to Collection

Review Respiratory System

New perspectives on the role of muscarinic antagonists in asthma therapy

Maria Gabriella Matera et al.

EXPERT REVIEW OF RESPIRATORY MEDICINE (2020)

Add to Collection

Editorial Material Allergy

The latest on the role of LAMAs in asthma

Mario Cazzola et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Add to Collection

Article Immunology

A Critical Role for the CXCL3/CXCL5/CXCR2 Neutrophilic Chemotactic Axis in the Regulation of Type 2 Responses in a Model of Rhinoviral-Induced Asthma Exacerbation

Leon A. Sokulsky et al.

JOURNAL OF IMMUNOLOGY (2020)

Add to Collection

Article Allergy

2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group

Michelle M. Cloutier et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Add to Collection

Review Respiratory System

Severe Asthma and Biological Therapy: When, Which, and for Whom

Paola Rogliani et al.

PULMONARY THERAPY (2020)

Add to Collection

Review Allergy

Asthma and COPD overlap: a treatable trait or common several treatable-traits?

J. Gaspar Marques et al.

EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Add to Collection

Article Allergy

Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study

Thomas B. Casale et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)

Add to Collection

Review Respiratory System

Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report

Vanessa M. McDonald et al.

EUROPEAN RESPIRATORY JOURNAL (2019)

Add to Collection

Review Medicine, Research & Experimental

Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases

Ioana Agache et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Add to Collection

Article Medicine, General & Internal

Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma

Richard Beasley et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Unmet therapeutic goals and potential treatable traits in a population of patients with severe uncontrolled asthma in Spain. ENEAS study

Luis Perez de Llano et al.

RESPIRATORY MEDICINE (2019)

Add to Collection

Review Cardiac & Cardiovascular Systems

Bronchodilators in subjects with asthma-related comorbidities

Mario Cazzola et al.

RESPIRATORY MEDICINE (2019)

Add to Collection

Review Genetics & Heredity

Evolving Concepts in Chronic Obstructive Pulmonary Disease Blood-Based Biomarkers

Mario Cazzola et al.

MOLECULAR DIAGNOSIS & THERAPY (2019)

Add to Collection

Editorial Material Respiratory System

Normalisation of MRI ventilation heterogeneity in severe asthma by dupilumab

Sarah Svenningsen et al.

THORAX (2019)

Add to Collection

Review Immunology

IL-33 Mediated Inflammation in Chronic Respiratory Diseases-Understanding the Role of the Member of IL-1 Superfamily

Agata Gabryelska et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection

Review Allergy

Hot Topic: Precision Medicine for Asthma-Has the Time Come?

Xingnan Li

CURRENT ALLERGY AND ASTHMA REPORTS (2019)

Add to Collection

Review Medicine, General & Internal

The efficacy and safety of long-term add-on treatment of azithromycin in asthma A systematic review and meta-analysis

Xiaohu Wang et al.

MEDICINE (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Acute effects of salbutamol on systemic vascular function in people with asthma

Linn E. Moore et al.

RESPIRATORY MEDICINE (2019)

Add to Collection

Review Immunology

Severe asthma phenotypes and endotypes

Ioana Agache

SEMINARS IN IMMUNOLOGY (2019)

Add to Collection

Review Critical Care Medicine

Inhaled Corticosteroid Therapy in Adult Asthma Time for a New Therapeutic Dose Terminology

Richard Beasley et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)

Add to Collection

Review Respiratory System

The many faces of asthma-chronic obstructive pulmonary disease overlap

Louis-Philippe Boulet et al.

CURRENT OPINION IN PULMONARY MEDICINE (2019)

Add to Collection

Review Pharmacology & Pharmacy

The Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma

Giancarlo Marone et al.

FRONTIERS IN PHARMACOLOGY (2019)

Add to Collection

Review Biochemistry & Molecular Biology

Targeting cell signaling in allergic asthma

Seyyed Shamsadin Athari

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)

Add to Collection

Review Medicine, General & Internal

Severe Asthma in Primary Care: Identification and Management

Jennifer L. Trevor et al.

AMERICAN JOURNAL OF MEDICINE (2018)

Add to Collection

Article Pharmacology & Pharmacy

Pharmacological mechanisms leading to synergy in fixed-dose dual bronchodilator therapy

Luigino Calzetta et al.

CURRENT OPINION IN PHARMACOLOGY (2018)

Add to Collection

Review Medicine, General & Internal

After asthma: redefining airways diseases

Ian D. Pavord et al.

LANCET (2018)

Add to Collection

Article Medicine, General & Internal

Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma

Paul M. O'Byrne et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Add to Collection

Article Critical Care Medicine

Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two randomised, double-blind, placebo-controlled, phase 3 clinical trials

Reynold A. Panettieri et al.

LANCET RESPIRATORY MEDICINE (2018)

Add to Collection

Review Immunology

IL-4 and IL-13 Receptor Signaling From 4PS to Insulin Receptor Substrate 2: There and Back Again, a Historical View

Achsah D. Keegan et al.

FRONTIERS IN IMMUNOLOGY (2018)

Add to Collection

Review Allergy

Anti-IgE or Anti-IL5: That Is the Question

Elliot Israel et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2018)

Add to Collection

Article Respiratory System

Risk Factors for Asthma Exacerbation and Treatment Failure in Adults and Adolescents with Well-controlled Asthma during Continuation and Step-Down Therapy

Emily DiMango et al.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2018)

Add to Collection

Article Respiratory System

Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways

Luigino Calzetta et al.

RESPIRATORY RESEARCH (2018)

Add to Collection

Article Pharmacology & Pharmacy

Ensifentrine (RPL554): an inhaled bifunctional' dual PDE3/4 inhibitor for the treatment of asthma and chronic obstructive pulmonary disease

Mario Cazzola et al.

PHARMACEUTICAL PATENT ANALYST (2018)

Add to Collection

Article Respiratory System

Inhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD

Claudio F. Donner et al.

MONALDI ARCHIVES FOR CHEST DISEASE (2018)

Add to Collection

Article Medicine, General & Internal

Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study

Akbar K. Waljee et al.

BMJ-BRITISH MEDICAL JOURNAL (2017)

Add to Collection

Review Medicine, General & Internal

Why and how to step down chronic asthma drugs

Michael R. Gionfriddo et al.

BMJ-BRITISH MEDICAL JOURNAL (2017)

Add to Collection

Article Medicine, General & Internal

Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study

Akbar K. Waljee et al.

BMJ-BRITISH MEDICAL JOURNAL (2017)

Add to Collection

Review Medicine, General & Internal

Why and how to step down chronic asthma drugs

Michael R. Gionfriddo et al.

BMJ-BRITISH MEDICAL JOURNAL (2017)

Add to Collection

Review Respiratory System

Role of muscarinic antagonists in asthma therapy

Mario Cazzola et al.

EXPERT REVIEW OF RESPIRATORY MEDICINE (2017)

Add to Collection

Review Respiratory System

Personalised medicine in asthma: from curative to preventive medicine

Laurent Guilleminault et al.

EUROPEAN RESPIRATORY REVIEW (2017)

Add to Collection

Review Medicine, General & Internal

Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma (Review)

Bhupendrasinh F. Chauhan et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)

Add to Collection

Article Allergy

Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology

Antonella Muraro et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)

Add to Collection

Article Pharmacology & Pharmacy

Interaction between corticosteroids and muscarinic antagonists in human airways

Mario Cazzola et al.

PULMONARY PHARMACOLOGY & THERAPEUTICS (2016)

Add to Collection

Review Cardiac & Cardiovascular Systems

Can bronchial asthma with an highly prevalent airway (and systemic) vagal tone be considered an independent asthma phenotype? Possible role of anticholinergics

Gennaro Liccardi et al.

RESPIRATORY MEDICINE (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

A 12-year prognosis of adult-onset asthma: Seinajoki Adult Asthma Study

Leena E. Tuomisto et al.

RESPIRATORY MEDICINE (2016)

Add to Collection

Article Critical Care Medicine

Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials

Nicola A. Hanania et al.

LANCET RESPIRATORY MEDICINE (2016)

Add to Collection

Article Respiratory System

Anti-inflammatory potential of PI3Kδ and JAK inhibitors in asthma patients

Thomas Southworth et al.

RESPIRATORY RESEARCH (2016)

Add to Collection

Article Critical Care Medicine

Evolving Concepts of Asthma

Marc Gauthier et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)

Add to Collection

Article Biochemistry & Molecular Biology

Strategies targeting the IL-4/IL-13 axes in disease

Richard D. May et al.

CYTOKINE (2015)

Add to Collection

Article Multidisciplinary Sciences

Seventy Years of Asthma in Italy: Age, Period and Cohort Effects on Incidence and Remission of Self-Reported Asthma from 1940 to 2010

Giancarlo Pesce et al.

PLOS ONE (2015)

Add to Collection

Article Immunology

Type 2 inflammation in asthma - present in most, absent in many

John V. Fahy

NATURE REVIEWS IMMUNOLOGY (2015)

Add to Collection

Article Pharmacology & Pharmacy

Defining Phenotypes in Asthma: A Step Towards Personalized Medicine

Kian Fan Chung

DRUGS (2014)

Add to Collection

Article Respiratory System

Bifunctional drugs for the treatment of asthma and chronic obstructive pulmonary disease

Clive Page et al.

EUROPEAN RESPIRATORY JOURNAL (2014)

Add to Collection

Article Allergy

Outcomes of childhood asthma to the age of 50 years

Andrew Tai et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)

Add to Collection

Article Critical Care Medicine

Exploring the Effects of Omalizumab in Allergic Asthma An Analysis of Biomarkers in the EXTRA Study

Nicola A. Hanania et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)

Add to Collection

Article Immunology

Differential Roles of CXCL2 and CXCL3 and Their Receptors in Regulating Normal and Asthmatic Airway Smooth Muscle Cell Migration

Laila A. Al-Alwan et al.

JOURNAL OF IMMUNOLOGY (2013)

Add to Collection

Article Respiratory System

Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial

Guy G. Brusselle et al.

THORAX (2013)

Add to Collection

Review Allergy

The potential use of tyrosine kinase inhibitors in severe asthma

Vamsi P. Guntur et al.

CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2012)

Add to Collection

Review Biochemistry & Molecular Biology

Asthma phenotypes: the evolution from clinical to molecular approaches

Sally E. Wenzel

NATURE MEDICINE (2012)

Add to Collection

Review Pharmacology & Pharmacy

Tremor and β2-adrenergic agents: Is it a real clinical problem?

Mario Cazzola et al.

PULMONARY PHARMACOLOGY & THERAPEUTICS (2012)

Add to Collection

Article Medicine, General & Internal

Effect of Bronchoconstriction on Airway Remodeling in Asthma

Christopher L. Grainge et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Add to Collection

Article Biochemistry & Molecular Biology

Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma

Xiaojin Liu et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)

Add to Collection

Article Pharmacology & Pharmacy

Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma

Thomas E. Delea et al.

CLINICAL THERAPEUTICS (2008)

Add to Collection

Article Respiratory System

Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison

I. S. T. Bos et al.

EUROPEAN RESPIRATORY JOURNAL (2007)

Add to Collection

Article Cardiac & Cardiovascular Systems

Use of oral corticosteroids and the risk of acute myocardial infarction

Cristina Varas-Lorenzo et al.

ATHEROSCLEROSIS (2007)

Add to Collection

Article Medicine, General & Internal

Corticosteroids and the risk of atrial fibrillation

Cornelis S. van der Hooft et al.

ARCHIVES OF INTERNAL MEDICINE (2006)

Add to Collection

Article Pharmacology & Pharmacy

Inhibition of Rho-kinase normalizes nonspecific hyperresponsiveness in passively sensitized airway smooth muscle preparations

D Schaafsma et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2006)

Add to Collection

Article Medicine, General & Internal

Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease

L Wei et al.

ANNALS OF INTERNAL MEDICINE (2004)

Add to Collection

Article Medicine, General & Internal

A longitudinal, population-based, cohort study of childhood asthma followed to adulthood

MR Sears et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)

Add to Collection

Article Biochemistry & Molecular Biology

Kinetic analysis of the interleukin-13 receptor complex

AL Andrews et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

Add to Collection

Article Biochemistry & Molecular Biology

Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma

DA Kuperman et al.

NATURE MEDICINE (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.